The trail enrolled 123 patients at 23 sites across the US and Europe.

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Data ...

The ALPHA-PE Research Fund is designed to support physician-led studies that advance understanding of pulmonary embolism and ...

Amid rapid changes in the field of acute pulmonary embolism (PE) treatment, the American Heart Association (AHA) has released a scientific statement summing up the current state of interventional ...

The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...

VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using ...

Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...

There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and ...

New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot ...

A pulmonary embolism (PE) is a blockage within an artery in the lungs. It is a potentially life threatening condition that requires prompt diagnosis and treatment. Pregnancy causes changes to hormones ...